This study applied mass spectrometry imaging to map lipid composition in mammary tissue from the MMTV‑PyMT mouse model of breast cancer. The MMTV‑PyMT model reproduces four stages of human breast tumor progression: hyperplasia, adenoma/mammary intraepithelial neoplasia (MIN), early carcinoma and late carcinoma. The comparison was made between two groups: mice with normal Cyp27b1 expression in the mammary epithelium (non‑ablated controls) and mice with conditional epithelial‑specific ablation of Cyp27b1. The authors previously reported that epithelial Cyp27b1 ablation enhanced spontaneous tumor initiation and progression in this model; the present work examines whether local loss of Cyp27b1 alters intratumoral lipid profiles.
Cyp27b1 encodes 1‑α‑hydroxylase, the enzyme that converts circulating 25‑hydroxyvitamin D (25(OH)D) into the bioactive hormone 1,25(OH)2D. Although the kidney is the major site for systemic 1,25(OH)2D synthesis, extra‑renal expression of Cyp27b1 occurs in tissues including the breast. Tumor‑produced 1,25(OH)2D has been implicated in mammary tumor biology and can affect lipid metabolism. The authors sought to determine whether the presence or absence of epithelial Cyp27b1 (and by implication local 1,25(OH)2D production) is associated with distinct lipid signatures during tumor progression.
In non‑ablated control animals, the imaging analysis revealed stage‑associated alterations in specific lipid signals. Several discriminatory lipid signals were observed to be significantly upregulated across stages of tumor progression from early lesions to carcinomas. These results indicate that as tumors progress in the MMTV‑PyMT model, the intratumoral lipid landscape shifts and that particular lipid ions or species can discriminate among progression stages.
When Cyp27b1 was conditionally ablated in the mammary epithelium, the pattern of lipid signals differed notably from controls, particularly at the hyperplasia stage. Hyperplastic lesions in Cyp27b1‑ablated mice exhibited different lipid signals compared with hyperplasia in non‑ablated animals. Importantly, several lipid signals that were present in non‑ablated tumors were absent in hyperplastic tissue from ablated mice. The observed differences suggest that local loss of Cyp27b1 modifies early lipid alterations that otherwise accompany tumor progression in this model.
The authors interpret the imaging results as evidence that tumor‑produced 1,25(OH)2D is mechanistically related to early changes in intratumoral lipid composition seen prior to and during the development of hyperplasia. Given earlier findings that epithelial Cyp27b1 ablation accelerates tumor initiation and progression in the MMTV‑PyMT model, the current lipidomic imaging data provide molecular context consistent with a role for local vitamin D metabolism in shaping the tumor lipid environment during early stages of mammary tumorigenesis.
This report is a preprint and has not undergone peer review. The source text does not report detailed methodological parameters, the specific lipid identities or m/z values, quantitative effect sizes, sample numbers, or statistical test results in the abstract; those details may be available in the full text and supplementary material referenced in the original source. The work was supported by the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada as noted in the source. The authors declared no competing interests.
The study highlights a potential mechanistic connection between local vitamin D activation by epithelial Cyp27b1 and early tumor lipid remodeling in a widely used mouse model of breast cancer. If validated and extended with identified lipid species, quantification, and functional follow‑up, these observations could inform research into how intratumoral vitamin D metabolism influences tumor metabolism and progression. Because this is a preprint, translation to clinical contexts requires further validation and peer‑reviewed confirmation.